UA39866C2 - Похідні індолу, проміжні сполуки, фармацевтична композиція та спосіб лікування - Google Patents

Похідні індолу, проміжні сполуки, фармацевтична композиція та спосіб лікування

Info

Publication number
UA39866C2
UA39866C2 UA94095775A UA94095775A UA39866C2 UA 39866 C2 UA39866 C2 UA 39866C2 UA 94095775 A UA94095775 A UA 94095775A UA 94095775 A UA94095775 A UA 94095775A UA 39866 C2 UA39866 C2 UA 39866C2
Authority
UA
Ukraine
Prior art keywords
mixer
treatment
pharmaceutical composition
intermediate compounds
case
Prior art date
Application number
UA94095775A
Other languages
English (en)
Ukrainian (uk)
Inventor
Джон Е. Мейкор
Йоланта Т. Новаковскі
Original Assignee
Пфайзер, Інк.
Пфайзер, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер, Інк., Пфайзер, Инк. filed Critical Пфайзер, Інк.
Publication of UA39866C2 publication Critical patent/UA39866C2/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
UA94095775A 1992-03-05 1993-03-03 Похідні індолу, проміжні сполуки, фармацевтична композиція та спосіб лікування UA39866C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84664092A 1992-03-05 1992-03-05
PCT/US1993/001667 WO1993018032A1 (en) 1992-03-05 1993-03-03 Indole derivatives as 5-ht1 agonists

Publications (1)

Publication Number Publication Date
UA39866C2 true UA39866C2 (uk) 2001-07-16

Family

ID=25298499

Family Applications (1)

Application Number Title Priority Date Filing Date
UA94095775A UA39866C2 (uk) 1992-03-05 1993-03-03 Похідні індолу, проміжні сполуки, фармацевтична композиція та спосіб лікування

Country Status (30)

Country Link
US (2) US5594014A (OSRAM)
EP (1) EP0629199B1 (OSRAM)
JP (1) JPH07121943B2 (OSRAM)
KR (1) KR0179073B1 (OSRAM)
CN (4) CN1032309C (OSRAM)
AT (1) ATE218566T1 (OSRAM)
AU (1) AU666716B2 (OSRAM)
BR (1) BR9306012A (OSRAM)
CA (1) CA2117643C (OSRAM)
CZ (1) CZ282652B6 (OSRAM)
DE (1) DE69331988T2 (OSRAM)
DK (1) DK0629199T3 (OSRAM)
EG (1) EG20416A (OSRAM)
ES (1) ES2176199T3 (OSRAM)
FI (1) FI930968A7 (OSRAM)
HU (1) HU219489B (OSRAM)
IL (1) IL104941A (OSRAM)
MX (1) MX9301197A (OSRAM)
MY (1) MY109298A (OSRAM)
NO (1) NO302617B1 (OSRAM)
NZ (1) NZ249755A (OSRAM)
PL (1) PL172388B1 (OSRAM)
PT (1) PT629199E (OSRAM)
RU (1) RU2124012C1 (OSRAM)
SK (1) SK281938B6 (OSRAM)
TW (1) TW288010B (OSRAM)
UA (1) UA39866C2 (OSRAM)
WO (1) WO1993018032A1 (OSRAM)
YU (1) YU14893A (OSRAM)
ZA (1) ZA931539B (OSRAM)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US6380233B1 (en) 1992-04-07 2002-04-30 Pfizer Inc Indole derivatives as 5-HT1 agonists
RU2101283C1 (ru) 1992-04-07 1998-01-10 Пфайзер Инк. Производные индола или их фармацевтически приемлемые соли
ATE170836T1 (de) * 1993-08-31 1998-09-15 Pfizer 5-arylindolderivate
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9420503D0 (en) * 1994-10-11 1994-11-23 Pfizer Ltd Therapeutic agents
GB9420529D0 (en) 1994-10-12 1994-11-30 Pfizer Ltd Indoles
EA199800611A1 (ru) * 1995-12-29 1999-04-29 Берингер, Ингельхайм Фармасьютиклс, Инк. Производные фенилтиазола с противогерпетическими свойствами
US6288091B1 (en) 1995-12-29 2001-09-11 Boehringer Ingelheim Ltd. Antiherpes virus compounds and methods for their preparation and use
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
MXPA03004623A (es) 2000-11-27 2003-09-05 Pfizer Prod Inc Agonistas selectivos del receptor ep4 en el tratamiento de la osteoporosis.
CA2444036A1 (en) * 2001-04-20 2002-10-31 Yanfang Li Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
ITRM20020255A1 (it) * 2002-05-09 2003-11-10 Polifarma Spa Tautomero enolico dell'acido 3-indolilpiruvico, suoi sali e usi terapeutici.
ES2199086B1 (es) * 2002-07-31 2005-06-01 Cepa Schwarz Pharma Sl Nuevos derivados de cicloalcanodionas, procedimiento para su preparacion y sus aplicaciones farmacologicas.
GB0317229D0 (en) * 2003-07-23 2003-08-27 Pfizer Ltd Improved process
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
AU2021215709A1 (en) * 2020-02-04 2022-09-01 Mindset Pharma Inc. 3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders
PL243119B1 (pl) * 2020-04-16 2023-06-26 Univ Jagiellonski Rozpuszczalne w wodzie modyfikowane pochodne aminokwasowe nadające się do leczenia chorób o podłożu neurologicznym oraz zaburzeń psychiatrycznych

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
ZA815541B (en) * 1980-08-12 1983-03-30 Glaxo Group Ltd Heterocyclic compounds
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
IL96891A0 (en) * 1990-01-17 1992-03-29 Merck Sharp & Dohme Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them
CA2042295A1 (fr) * 1990-05-15 1991-11-16 Jacques Chauveau Derives de mediateurs endogenes, leurs sels, procede de preparation, applications, et compositions les renfermant
SI21560B (sl) * 1990-06-07 2005-04-30 Astrazeneca Ab 3,5-disubstituirani indolni derivati kot "5-HT1-podobni" receptorski agonisti
CA2091562C (en) * 1990-10-15 2001-03-27 John Eugene Macor Indole derivatives useful in psychotherapeutics
US5208248A (en) * 1991-01-11 1993-05-04 Merck Sharpe & Dohme, Ltd. Indazole-substituted five-membered heteroaromatic compounds
CZ283018B6 (cs) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
TW263508B (OSRAM) * 1991-02-12 1995-11-21 Pfizer

Also Published As

Publication number Publication date
MX9301197A (es) 1993-09-01
NZ249755A (en) 1996-08-27
JPH07500353A (ja) 1995-01-12
HU219489B (hu) 2001-04-28
KR0179073B1 (ko) 1999-03-20
YU14893A (sh) 1996-05-20
DE69331988T2 (de) 2002-09-19
CZ212594A3 (en) 1995-06-14
CA2117643C (en) 2000-03-14
JPH07121943B2 (ja) 1995-12-25
CN1032309C (zh) 1996-07-17
ZA931539B (en) 1994-09-05
FI930968A0 (fi) 1993-03-04
NO943261L (no) 1994-09-02
ES2176199T3 (es) 2002-12-01
IL104941A0 (en) 1993-07-08
HUT64061A (en) 1993-11-29
CN1082815C (zh) 2002-04-17
MY109298A (en) 1996-12-31
IL104941A (en) 1998-06-15
PL172388B1 (pl) 1997-09-30
RU94040914A (ru) 1996-08-10
PT629199E (pt) 2002-09-30
SK105294A3 (en) 1995-05-10
DE69331988D1 (de) 2002-07-11
DK0629199T3 (da) 2002-07-15
EP0629199A1 (en) 1994-12-21
RU2124012C1 (ru) 1998-12-27
CN1082044A (zh) 1994-02-16
SK281938B6 (sk) 2001-09-11
HU9300593D0 (en) 1993-05-28
CN1136566A (zh) 1996-11-27
ATE218566T1 (de) 2002-06-15
AU666716B2 (en) 1996-02-22
CZ282652B6 (cs) 1997-08-13
CA2117643A1 (en) 1993-09-16
WO1993018032A1 (en) 1993-09-16
CN1136565A (zh) 1996-11-27
TW288010B (OSRAM) 1996-10-11
CN1044909C (zh) 1999-09-01
US5717102A (en) 1998-02-10
KR950700291A (ko) 1995-01-16
AU3733093A (en) 1993-10-05
CN1136432A (zh) 1996-11-27
BR9306012A (pt) 1997-11-18
FI930968A7 (fi) 1993-09-06
NO302617B1 (no) 1998-03-30
EP0629199B1 (en) 2002-06-05
CN1044910C (zh) 1999-09-01
EG20416A (en) 1999-02-28
US5594014A (en) 1997-01-14
NO943261D0 (no) 1994-09-02

Similar Documents

Publication Publication Date Title
UA39866C2 (uk) Похідні індолу, проміжні сполуки, фармацевтична композиція та спосіб лікування
CA2430792A1 (en) Sealing composition
EA200400421A1 (ru) Способы управления выпадением расклинивающего материала при гидравлическом разрыве пласта
DE69533473D1 (de) Verarbeitung von pflantzlichem material mit xylanase
MY115714A (en) Oil and gas field chemicals
EA200101055A1 (ru) Способ и оборудование для уменьшения образования отложений в нагнетательных и добывающих скважинах
ES442786A1 (es) Procedimiento de saneamiento de efluentes procedentes de perforaciones petroliferas.
TW200517501A (en) Process for producing cytotoxic lymphocytes
MXPA03008297A (es) Composicion obturadora.
UA39932C2 (uk) Система санкціонованого доступу в салон транспортного засобу
GR3037016T3 (en) A method of treating cement clinker
SU1410596A1 (ru) Способ разработки нефтегазовых залежей с небольшой по толщине водоплавающей нефтяной оторочкой
RU92010449A (ru) Тампонажная композиция
RU2091569C1 (ru) Способ разработки неоднородной нефтяной залежи
RU95107265A (ru) Способ изоляции водопритоков в нефтяной скважине
JPS5754593A (en) Preparation of valienamine
SU1653407A1 (ru) Способ освоения скважин
NO164310C (no) Fremgangsmaate for behandling av en mekanisk masse med hydrosulfitt-blekekjemikalier.
SU1800868A1 (ru) Способ увеличения охвата неоднородных пластов заводнением
HU9601367D0 (en) Method for inactivation of pearlite
UA30137C2 (uk) Спосіб підйому пульпи
SU1490090A1 (ru) Способ очистки лигнинсодержащих сточных вод
SU817220A1 (ru) Способ подачи реагента
RU95101428A (ru) Способ получения и подачи ячеистого бетона неавтоклавного твердения
RU1790670C (ru) Способ приготовлени тампонажного раствора